|
51. (Journal Article): {alpha}L integrin I domain cyclic peptide antagonist selectively inhibits T cell adhesion to pancreatic islet microvascular endothelium
Huang M, Matthews K, Siahaan TJ, Kevil CG ABSTRACT:
Insulitis is a hallmark feature of autoimmune diabetes that ultimately results in islet beta cell destruction. We examined integrin requirements and specific inhibition of integrin...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T1DM
»
Re-establishing Tole...
»
Modifying Immunity
»
Past Onset
»
Site-Specific Interv...
»
Journal Article
submitted: Aug 22, 2004 |
|
52. (Journal Article): Bcl-2 protection of islet allografts is unmasked by costimulation blockade
Sutherland RM, Allison J, Thomas HE, Brady JL, Kay TW, Lew AM ABSTRACT:
One major limitation in pancreatic islet transplantation is availability of donor tissue. Donor shortage is exacerbated by islet apoptosis from the stresses of islet isolation and ...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T1DM
»
Immunosuppression
»
Journal Article
submitted: Aug 25, 2004 |
|
53. (Journal Article): Dominant negative MyD88 proteins inhibit interleukin-1beta /interferon-gamma-mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells.
Dupraz P, Cottet S, Hamburger F, Dolci W, Felley-Bosco E, Thorens B ABSTRACT:
Insulin-dependent diabetes mellitus is an autoimmune disease in which pancreatic islet beta cells are destroyed by a combination of immunological and inflammatory mechanisms. In pa...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T1DM
»
Beta-Cell Protection
»
Cytokine suppression
»
Inhibition of NF-kB ...
»
Journal Article
submitted: Jan 07, 2006 |
|
54. (Journal Article): A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets.
Grey ST, Arvelo MB, Hasenkamp W, Bach FH, Ferran C ABSTRACT:
Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease resulting from apoptotic destruction of beta cells in the islets of Langerhans. Low expression of antioxidants a...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T1DM
»
Beta-Cell Protection
»
Cytokine suppression
»
Inhibition of NF-kB ...
»
Journal Article
submitted: Jan 07, 2006 |
|
55. (Journal Article): Vitamin D target proteins: function and regulation.
Christakos S, Barletta F, Huening M, Dhawan P, Liu Y, Porta A, Peng X ABSTRACT:
Recent findings have indicated that calbindin-D(28k), the first known target of vitamin D action, is present in osteoblasts and protects against TNF and glucocorticoid induced apop...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T1DM
»
Beta-Cell Protection
»
Calcium-Binding Prot...
»
Journal Article
submitted: May 27, 2005 |
|
56. (Journal Article): Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.
DeFronzo RA ABSTRACT:
n.a.
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T2DM
»
Insulinotropic Subst...
»
Incretins
»
GLP-1
»
Journal Article
submitted: Nov 16, 2005 |
|
57. (Journal Article): No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose.
Vilsboll T, Krarup T, Madsbad S, Holst JJ ABSTRACT:
AIMS: It has previously been shown that intravenous and subcutaneous administration of glucagon-like peptide (GLP)-1 concomitant with intravenous glucose results in reactive hypogl...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T2DM
»
Insulinotropic Subst...
»
Incretins
»
GLP-1
»
Hypoglycemia
»
Journal Article
submitted: Nov 16, 2005 |
|
58. (Journal Article): Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone.
Matsuyama T, Komatsu R, Namba M, Watanabe N, Itoh H, Tarui S ABSTRACT:
Glucagon-like peptide-1 (GLP-1) (1-37) and the fraction derived from it, GLP-1 (7-36 amide), are peptides encoded by the preproglucagon gene and possibly co-secreted with enteroglu...
|
»
Diabetes OD
»
Reversal/Prevention ...
»
T2DM
»
Insulinotropic Subst...
»
Incretins
»
GLP-1
»
Preproglucagon Gene
»
Journal Article
submitted: Nov 16, 2005 |
|
59. (Journal Article): Eighty years after insulin: parallels with modern islet transplantation.
Shapiro J ABSTRACT:
This year marks the 80th anniversary of the publication in CMAJ of the discovery of insulin by Frederick Banting and his colleagues at the University of Toronto. Some interesting h...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Transplantation
»
Islet Cells
»
Journal Article
submitted: Jan 15, 2006 |
|
60. (Journal Article): Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets.
Klein D, Ribeiro MM, Mendoza V, Jayaraman S, Kenyon NS, Pileggi A, Molano RD, Inverardi L, Ricordi C, Pastori RL ABSTRACT:
Viability of isolated islets is one of the main obstacles limiting islet transplantation success. It has been reported that overexpression of Bcl-2/Bcl-XL proteins enhances islet v...
|
»
Diabetes OD
»
Regeneration of Isle...
»
Transplantation
»
Islet Cells
»
Inhibition of Apopto...
»
Anti-Apoptotic Prote...
»
Bcl-2
»
Journal Article
submitted: Jan 07, 2006 |
|